Canada, US Hold Fresh Trade Talks as August 19 Tariff Deadline Nears 
Zelenskiy Sends Peace Plan to U.S., Warns of New Russian Mobilisation 
Putin Visits Japan-Claimed Iturup Island, Drawing Strong Protest From Tokyo 
Missile Threat Forced Trump to Secretly Switch Air Force One in Turkey 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Albanese Says AUKUS ‘Full Steam Ahead’ After Trump Call 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
Israel Warned US of Alleged Iran Plot to Assassinate Trump 
Peggy Flanagan Wins Minnesota Democratic Senate Nomination 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Trump Orders U.S. Navy to Return to Steam Catapults for Aircraft Carriers 
Bashar al-Assad Sentenced to Death by Syrian Court 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Israeli Troops Enter Qusra Homes as West Bank Settler Siege Continues 
Add as a preferred source on Google
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
